Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lipoic Acid Supplement for Cystine Stone
Sponsor: Thomas Chi, MD
Summary
This study evaluates how daily alpha lipoic acid supplementation affects cystine kidney stone recurrence. Half of the subjects will receive 1200 mg alpha lipoic acid orally daily for three years, while the other half will receive a placebo. The funding source for this clinical trial is FDA OOPD.
Official title: The Effect of Lipoic Acid Natural Supplement on Cystine Stone Formation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2017-06-19
Completion Date
2025-06
Last Updated
2023-12-20
Healthy Volunteers
No
Conditions
Interventions
Alpha lipoic acid
Already mentioned in arm/group descriptions.
Placebo
Already mentioned in arm/group descriptions.
Locations (1)
University of California, San Francisco
San Francisco, California, United States